Overview

Study of Efficacy and Safety of Laparoscopic Intra-abdominal Chemotherapy (PIPAC) Performed in Patients With Peritoneal Carcinomatosis From Colorectal, Ovarian, Gastric Cancer and Primary Peritoneal Tumors

Status:
Completed

Trial end date:
2020-05-31

Target enrollment:

Participant gender:

Summary

Single center, open label, phase I-II, non-randomized, two-cohort, repeated single dose study to explore the feasibility, efficacy, safety, and Overall Response Rate (ORR) of oxaliplatin, or cisplatin and doxorubicin when given as a pressurized intraperitoneal chemotherapy (PIPAC) to patients (men and women) with peritoneal carcinomatosis from ovarian, gastric and colorectal cancers and in primary cancers of peritoneum.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Fondazione del Piemonte per l'Oncologia

Treatments:

Cisplatin
Doxorubicin
Liposomal doxorubicin
Oxaliplatin